Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell H Wiesner

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 2015
In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?Russell H Wiesner
Hepatology (Baltimore, Md.)|April 27, 2011
Apply sound scientific methodology to the evaluation of new medical treatmentsRussell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's diseaseRussell H Wiesner
Hepatology (Baltimore, Md.)|November 26, 2008
Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitisRussell H Wiesner
Clinics in Liver Disease|July 15, 2014
Evolving trends in liver transplantation: listing and liver donor allocationRussell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2005
Evidence-based evolution of the MELD/PELD liver allocation policyRussell H Wiesner
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Patient selection in an era of donor liver shortage: current US policyRussell H Wiesner
Journal of Hepatology|July 12, 2011
The use of sirolimus should be restricted in liver transplantationOmar Massoud, Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2011
Present state of immunosuppressive therapy in liver transplant recipientsRussell H Wiesner, John J Fung
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 2015
In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?Russell H Wiesner
Hepatology (Baltimore, Md.)|April 27, 2011
Apply sound scientific methodology to the evaluation of new medical treatmentsRussell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's diseaseRussell H Wiesner
Hepatology (Baltimore, Md.)|November 26, 2008
Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitisRussell H Wiesner
Clinics in Liver Disease|July 15, 2014
Evolving trends in liver transplantation: listing and liver donor allocationRussell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2005
Evidence-based evolution of the MELD/PELD liver allocation policyRussell H Wiesner
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Patient selection in an era of donor liver shortage: current US policyRussell H Wiesner
Journal of Hepatology|July 12, 2011
The use of sirolimus should be restricted in liver transplantationOmar Massoud, Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2011
Present state of immunosuppressive therapy in liver transplant recipientsRussell H Wiesner, John J Fung
Pageof 8